Portfolio News

Linden Capital Partners acquires Alcresta Therapeutics inc.

12 March 2024
< Back to News

Chicago, IL and Waltham, MA (March 12, 2024) – Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the completion of its acquisition of Alcresta Therapeutics, Inc. ("Alcresta"), a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases, from Athyrium Capital, Bessemer Venture Partners, Frazier Healthcare Partners, and HealthQuest Capital. HealthQuest Capital subsequently re-invested in Alcresta and will continue as a minority shareholder and board member.

Read the full press release here

Speak to us.

 

Contact Us.